Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Eitemau Tebyg

• Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
  gan: Meredith, I, et al.
  Cyhoeddwyd: (2013)
• A novel bioabsorbable drug-eluting tracheal stent
  gan: Zhu, G. H., et al.
  Cyhoeddwyd: (2011)
• Thrombotic occlusion of a drug-eluting stent - is IVUS mandatory.
  gan: Arnold, JR, et al.
  Cyhoeddwyd: (2006)
• Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
  gan: Stone, GW, et al.
  Cyhoeddwyd: (2016)
• Treatment of spontaneous coronary dissection with drug-eluting stents--late clinical, angiographic and IVUS follow up.
  gan: van Gaal, W, et al.
  Cyhoeddwyd: (2006)